[
  {
    "ts": "2026-02-11T12:00:00+00:00",
    "headline": "Robert A. Winn Excellence in Clinical Trials Award Program Announces Third Cohort of Physician-Researchers for the Clinical Investigator Leadership Award",
    "summary": "Bristol Myers Squibb Foundation is proud to support Conquer Cancer's EveryGrant and the American Heart Association to Advance Clinical Trials Leadership in Oncology and Cardiovascular Research Originally published by The Robert A. Winn Excellence ...",
    "url": "https://finance.yahoo.com/news/robert-winn-excellence-clinical-trials-120000273.html",
    "source": "ACCESS Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "d9470352-2683-3fce-98ec-27cf5d273b37",
      "content": {
        "id": "d9470352-2683-3fce-98ec-27cf5d273b37",
        "contentType": "STORY",
        "title": "Robert A. Winn Excellence in Clinical Trials Award Program Announces Third Cohort of Physician-Researchers for the Clinical Investigator Leadership Award",
        "description": "",
        "summary": "Bristol Myers Squibb Foundation is proud to support Conquer Cancer's EveryGrant and the American Heart Association to Advance Clinical Trials Leadership in Oncology and Cardiovascular Research Originally published by The Robert A. Winn Excellence ...",
        "pubDate": "2026-02-11T12:00:00Z",
        "displayTime": "2026-02-11T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/accesswire.ca/db51e10b9079879da85da03096a12022",
          "originalWidth": 1000,
          "originalHeight": 800,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/r82eqlOhciU69BXKdmA_Cw--~B/aD04MDA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/accesswire.ca/db51e10b9079879da85da03096a12022.cf.webp",
              "width": 1000,
              "height": 800,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EzdVZzywi9XuC4TtoJHQew--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/db51e10b9079879da85da03096a12022.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "ACCESS Newswire",
          "url": "https://www.accessnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/robert-winn-excellence-clinical-trials-120000273.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/robert-winn-excellence-clinical-trials-120000273.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T14:00:05+00:00",
    "headline": "Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-company-bmy-140005207.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "d8d5f8ba-7f0e-3bed-9660-6b2550329514",
      "content": {
        "id": "d8d5f8ba-7f0e-3bed-9660-6b2550329514",
        "contentType": "STORY",
        "title": "Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It",
        "description": "",
        "summary": "Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
        "pubDate": "2026-02-11T14:00:05Z",
        "displayTime": "2026-02-11T14:00:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/090f58c1efbe3555b861102525e50b39",
          "originalWidth": 900,
          "originalHeight": 601,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yNgUIaj6nVgElt8k_HeWJg--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/090f58c1efbe3555b861102525e50b39.cf.webp",
              "width": 900,
              "height": 601,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pjdR96PEF4KSKZclyxD5FQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/090f58c1efbe3555b861102525e50b39.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-company-bmy-140005207.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-company-bmy-140005207.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T22:31:00+00:00",
    "headline": "EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight",
    "summary": "DelveInsight's EGFR-NSCLC Market Insights report includes a comprehensive understanding of current treatment practices, EGFR-NSCLC emerging drugs, market share of individual therapies, and current and forecasted market size from 2020 to 2034, segmented into leading markets [the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan].",
    "url": "https://finance.yahoo.com/news/egfr-nsclc-market-observe-stunning-223100002.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "67d39ae9-b16f-3d54-b275-58069cbea542",
      "content": {
        "id": "67d39ae9-b16f-3d54-b275-58069cbea542",
        "contentType": "STORY",
        "title": "EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight",
        "description": "",
        "summary": "DelveInsight's EGFR-NSCLC Market Insights report includes a comprehensive understanding of current treatment practices, EGFR-NSCLC emerging drugs, market share of individual therapies, and current and forecasted market size from 2020 to 2034, segmented into leading markets [the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan].",
        "pubDate": "2026-02-11T22:31:00Z",
        "displayTime": "2026-02-11T22:31:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/9711e6be91b3534a074e21a35fd57d95",
          "originalWidth": 400,
          "originalHeight": 181,
          "caption": "DelveInsight Logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KAOnJnJW7AvXzb_irAdD3w--~B/aD0xODE7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/9711e6be91b3534a074e21a35fd57d95.cf.webp",
              "width": 400,
              "height": 181,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/b5Q8EO062JYIoob3yognYQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/9711e6be91b3534a074e21a35fd57d95.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/egfr-nsclc-market-observe-stunning-223100002.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/egfr-nsclc-market-observe-stunning-223100002.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "AVBP"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]